个人介绍
姜继宗，博士，中国科学院上海药物研究所博士后。主要从事基于纳米技术调控肿瘤代谢通路、药物新剂型与体内过程、中药新剂型等。代表性论文发表在《Drug Development and Industrial Pharmacy》、《Applied Materials Today》、《Toxicology in Vitro》等杂志，主持国家自然科学基金青年科学基金1项。


主要研究方向

分子药剂学


代表性学术成果
论文
1.Jiang JZ^#, Ma TY^#, Zhang LH, Cheng XM, Wang CH. The transdermal performance, pharmacokinetics and anti-inflammatory pharmacodynamics evaluation of harmine-loaded ethosomes. Drug Development and Industrial Pharmacy. Drug Development and Industrial Pharmacy. 2020, 46(1): 101-108.
2. Chang Y^#, Jiang JZ^#, Chen W, Yang W, Chen LL, Qian SZ, Zhou T, Wu LF, Hong LH, Huang YZ, Li F. Biomimetic Metal-organic Nanoparticles Prepared with a 3D-printed Microfluidic Device as a Novel Formulation for Disulfiram-based Therapy against Breast Cancer. Applied Materials Today, 2019, DOI:10.1016/j.apmt.2019.100492.
3. Jiang JZ, Yang BH, Ji LL, Yang L, Mao YC, Hu ZH, Wang ZT, Wang CH. Metabolic-induced cytotoxicity of diosbulbin B in CYP3A4-expressing cells, Toxicology in Vitro, 2017, 38(2): 59-66.
4. Yang LJ, Jiang JZ, Hong JY, Di J, Liao YH, Kuang HX, Wang XT. High drug payload 10-Hydroxycamptothecin nanosuspensions stabilized by cholesterol-PEG: in vitro and in vivo investigation, Journal of Biomedical Nanotechnology, 2015, 11(4): 711-721.







上一条：刘天琪
下一条：陈雪瑞